Hood River Capital Management LLC Takes $29.02 Million Position in Enovis Co. (NYSE:ENOV)

Hood River Capital Management LLC acquired a new position in shares of Enovis Co. (NYSE:ENOV - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 661,430 shares of the company's stock, valued at approximately $29,024,000. Hood River Capital Management LLC owned approximately 1.16% of Enovis as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Confluence Investment Management LLC purchased a new position in Enovis during the fourth quarter valued at approximately $3,494,000. Geode Capital Management LLC grew its holdings in shares of Enovis by 9.5% during the 3rd quarter. Geode Capital Management LLC now owns 921,437 shares of the company's stock valued at $39,678,000 after acquiring an additional 80,165 shares in the last quarter. UMB Bank n.a. increased its stake in shares of Enovis by 128.2% in the fourth quarter. UMB Bank n.a. now owns 778 shares of the company's stock worth $34,000 after acquiring an additional 437 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its holdings in shares of Enovis by 19.5% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,433 shares of the company's stock worth $677,000 after acquiring an additional 2,518 shares in the last quarter. Finally, Assenagon Asset Management S.A. acquired a new stake in Enovis during the fourth quarter valued at $437,000. 98.45% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Needham & Company LLC restated a "buy" rating and issued a $64.00 price objective on shares of Enovis in a report on Wednesday, April 9th.

Enovis Stock Down 2.0 %

Shares of NYSE:ENOV traded down $0.69 on Monday, reaching $34.42. The company had a trading volume of 289,186 shares, compared to its average volume of 750,093. The company has a quick ratio of 1.12, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $1.97 billion, a P/E ratio of -15.71 and a beta of 1.86. The stock has a 50-day moving average price of $36.51 and a 200 day moving average price of $42.00. Enovis Co. has a twelve month low of $29.32 and a twelve month high of $56.43.

Enovis (NYSE:ENOV - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.92 by $0.06. The company had revenue of $560.98 million during the quarter, compared to analysts' expectations of $555.14 million. Enovis had a negative net margin of 5.95% and a positive return on equity of 4.39%. On average, equities analysts expect that Enovis Co. will post 2.79 EPS for the current year.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.